RG
HZNP

Redmile Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Redmile Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$72.8M Buy
2019
Q4 		– Sell
2019
Q3 		$400K Buy
2019
Q2 		$274K Buy
2018
Q3 		– Sell
2018
Q2 		$427K Buy
2018
Q1 		$284K Hold
2017
Q4 		$292K Buy